Evidence map›Paper›PMID 35258989›Full record

ArticleJCO global oncology2022

Global Oncology Authorship and Readership Patterns.

Maria T Bourlon, Brenda Jiménez Franco, Francisco J Castro-Alonso, Christianne Bourlon, Charbel F Matar, Emilie Gunn, Ophira Ginsburg, Gilberto Lopes, Eva Segelov

Abstract read
In one paragraph

Article in JCO global oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Maria T BourlonInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.ORCID 0000-0002-3116-912X
Brenda Jiménez FrancoInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Francisco J Castro-AlonsoHospital Regional de Alta Especialidad de Oaxaca, Mexico City, Mexico.
Christianne BourlonInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.ORCID 0000-0002-6284-6269
Charbel F MatarAmerican University of Beirut Medical Center, Beirut, Lebanon.ORCID 0000-0001-7105-7408
Emilie GunnAmerican Society of Clinical Oncology, Alexandria, VA.ORCID 0000-0001-6833-0928
Ophira GinsburgPerlmutter Cancer Center, NYU Grossman School of Medicine, New York City, NY.
Gilberto LopesUniversity of Miami Miller School of Medicine, Miami, FL.ORCID 0000-0002-1151-9903
Eva SegelovMonash University and Monash Health, Subang Jaya, Malaysia.ORCID 0000-0002-4410-6144

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeGlobal Oncology is the movement to improve equitable access to cancer control and care, recognizing challenges because of economic and social factors between high-, middle-, and low-income countries (HIC, MIC, and LIC, respectively). The

methodsMetadata of logged views between January 1, 2018, and June 30, 2019, of articles published in 2018 by

resultsOne hundred thirty-two articles were published in

conclusionMore than half of

Indexed as

AuthorshipPublicationsIncomeMedical OncologyPoverty

Identifiers

PMID35258989
PMCPMC8920442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.